Biotechs struggle as IPOs find cool reception

Biotechs struggle as IPOs find cool reception
“Five initial public offerings had trading debuts Thursday, bringing mixed results and a message that biotech certainly isn’t what the doctor ordered for the IPO market. “

Biotechblog
Scroll to Top